RIP2 Polyclonal Antibody

RIPK2 (receptor interacting serine/threonine kinase 2) encodes a member of the receptor-interacting protein (RIP) family of serine/threonine protein kinases. The encoded protein contains a C-terminal caspase activation and recruitment domain (CARD), and is a component of signaling complexes in both the innate and adaptive immune pathways. It is a potent activator of NF-kappaB and inducer of apoptosis in response to various stimuli.

The RIP2 Polyclonal Antibody is a highly specific and sensitive antibody that has been designed to detect and quantify the presence of receptor-interacting protein 2 (RIP2) in various biological samples. This antibody has been extensively validated for use in a wide range of applications, including Western blotting, immunohistochemistry, and immunofluorescence.

The RIP2 Polyclonal Antibody has been produced using high-quality materials and state-of-the-art techniques to ensure maximum specificity and sensitivity. It has been purified using a combination of protein A and protein G chromatography, and has been extensively characterized to ensure that it meets the highest standards of quality and performance.

This antibody is suitable for use in a variety of research applications, including studies of inflammation, apoptosis, and immune response. It has been shown to be highly effective in detecting RIP2 in a variety of cell types and tissues, and has been used successfully in numerous published studies.

Overall, the RIP2 Polyclonal Antibody is a reliable and effective tool for researchers who are studying the role of RIP2 in various biological processes. Its high specificity and sensitivity make it an ideal choice for a wide range of applications, and its quality and performance have been extensively validated to ensure that it meets the highest standards of excellence.